Precigen, Inc.
PGEN
$4.15
$0.071.72%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/13/2026
-
Zacks Investment Research
5/13/2026
-
Fool.com Headlines
5/13/2026
-
PR Newswire
5/8/2026
-
Simply Wall St
5/7/2026
-
PR Newswire
5/6/2026
-
MarketBeat
5/6/2026
-
Tickeron - Stocks
5/6/2026
-
Tickeron - Stocks
5/6/2026
-
Simply Wall St
5/5/2026
-
MarketBeat
5/3/2026
-
Yahoo! Finance: News
5/3/2026
-
Insider Monkey
5/1/2026
-
Tickeron - Stocks
4/29/2026
-
Zacks Investment Research
4/29/2026
-
Zacks Investment Research
4/29/2026
-
Tickeron - Stocks
4/26/2026
-
MarketBeat
4/25/2026
-
Tickeron - Technical Analysis
4/25/2026
-
Tickeron - Technical Analysis
4/24/2026
-
Tickeron - Stocks
4/24/2026
-
Tickeron - Stocks
4/21/2026
-
Tickeron - Technical Analysis
4/21/2026
-
Tickeron - Technical Analysis
4/20/2026
-
MarketBeat
4/18/2026
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, March 25, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
301 556 9900
Address
20374 Seneca Meadows Parkway
Germantown, MD 20876
Germantown, MD 20876
Country
Year Founded
Business Description
Sector
Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune...
more